• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives.糖尿病肾病与心脏-肾脏综合征:旧病新视角。
Endocrinol Metab Clin North Am. 2013 Dec;42(4):789-808. doi: 10.1016/j.ecl.2013.06.002. Epub 2013 Aug 1.
2
[New therapeutic options in renal diseases--hypotensive therapy].
Pol Arch Med Wewn. 2004 Oct;112 Spec No:57-63.
3
Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.糖尿病肾病中肾素-血管紧张素系统的单药与联合阻断治疗(血管紧张素转换酶抑制剂和/或血管紧张素II受体阻滞剂)
Curr Opin Nephrol Hypertens. 2004 May;13(3):319-24. doi: 10.1097/00041552-200405000-00009.
4
[Blood pressure goal and antihypertensive therapy in chronic kidney disease].[慢性肾脏病的血压目标与降压治疗]
Dtsch Med Wochenschr. 2014 Nov;139(48):2453-7. doi: 10.1055/s-0034-1387416. Epub 2014 Nov 19.
5
[Nephrotic syndrome due to metabolic disease--special reference to diabetic nephropathy].[代谢性疾病所致肾病综合征——特别提及糖尿病肾病]
Nihon Rinsho. 2004 Oct;62(10):1907-13.
6
[Risk and prevention of diabetic nephropathy].[糖尿病肾病的风险与预防]
G Ital Nefrol. 2007 Sep-Oct;24 Suppl 38:13-9.
7
Novel insights in the treatment of diabetic nephropathy.
Acta Clin Belg. 2007 Sep-Oct;62(5):278-90. doi: 10.1179/acb.2007.043.
8
[Treatment recommendations for various stages in diabetic nephropathy].[糖尿病肾病各阶段的治疗建议]
Nihon Rinsho. 2005 Jun;63 Suppl 6:379-83.
9
Treating hypertension in the patient with overt diabetic nephropathy.治疗显性糖尿病肾病患者的高血压。
Semin Nephrol. 2007 Mar;27(2):182-94. doi: 10.1016/j.semnephrol.2007.01.005.
10
SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease.钠-葡萄糖协同转运蛋白2抑制剂:糖尿病肾病联合治疗的新选择。
Cardiovasc Diabetol. 2017 May 16;16(1):65. doi: 10.1186/s12933-017-0547-1.

引用本文的文献

1
Association of advanced chronic kidney disease with diabetic retinopathy severity in older patients with diabetes: a retrospective cross-sectional study.老年糖尿病患者中晚期慢性肾脏病与糖尿病视网膜病变严重程度的相关性:一项回顾性横断面研究
J Yeungnam Med Sci. 2023 Apr;40(2):146-155. doi: 10.12701/jyms.2022.00206. Epub 2022 May 26.
2
Changing the Concept: From the Traditional Glucose-centric to the New Cardiorenal-metabolic Approach for the Treatment of Type 2 Diabetes.转变观念:从传统的以葡萄糖为中心到治疗2型糖尿病的新的心肾代谢方法。
touchREV Endocrinol. 2021 Nov;17(2):92-101. doi: 10.17925/EE.2021.17.2.92. Epub 2021 Nov 17.
3
Deciphering key genes in cardio-renal syndrome using network analysis.使用网络分析破译心肾综合征中的关键基因。
Bioinformation. 2021 Jan 31;17(1):86-100. doi: 10.6026/97320630017086. eCollection 2021.
4
Serum netrin and VCAM-1 as biomarker for Egyptian patients with type IΙ diabetes mellitus.血清网蛋白和血管细胞黏附分子-1作为埃及Ⅱ型糖尿病患者的生物标志物。
Biochem Biophys Rep. 2021 Jun 11;27:101045. doi: 10.1016/j.bbrep.2021.101045. eCollection 2021 Sep.
5
Ginsenoside Rg1 Alleviates Podocyte EMT Passage by Regulating AKT/GSK3 /-Catenin Pathway by Restoring Autophagic Activity.人参皂苷Rg1通过恢复自噬活性调节AKT/GSK3/β-连环蛋白通路减轻足细胞上皮-间质转化进程
Evid Based Complement Alternat Med. 2020 Jan 30;2020:1903627. doi: 10.1155/2020/1903627. eCollection 2020.
6
Association of unhealthy dietary behaviors with renal function decline in patients with diabetes.糖尿病患者不健康的饮食行为与肾功能下降的关系。
BMJ Open Diabetes Res Care. 2020 Jan;8(1). doi: 10.1136/bmjdrc-2019-000743.
7
Type 2 diabetes mellitus in the Goto-Kakizaki rat impairs microvascular function and contributes to premature skeletal muscle fatigue.Goto-Kakizaki 大鼠的 2 型糖尿病会损害微血管功能,并导致骨骼肌过早疲劳。
J Appl Physiol (1985). 2019 Mar 1;126(3):626-637. doi: 10.1152/japplphysiol.00751.2018. Epub 2018 Dec 20.
8
Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy.人参皂苷Rg1与黄芪甲苷联合应用可减轻糖尿病肾病大鼠的氧化应激并抑制肾纤维化中的TGF-β1/Smads信号级联反应。
Drug Des Devel Ther. 2018 Oct 18;12:3517-3524. doi: 10.2147/DDDT.S171286. eCollection 2018.
9
Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.管理慢性肾脏病患者的糖尿病和心血管风险。
Endocrinol Metab Clin North Am. 2018 Mar;47(1):237-257. doi: 10.1016/j.ecl.2017.10.006. Epub 2017 Dec 18.
10
Fructose: Toxic effect on cardiorenal risk factors and redox state.果糖:对心脏肾脏风险因素及氧化还原状态的毒性作用。
SAGE Open Med. 2016 Dec 14;4:2050312116684294. doi: 10.1177/2050312116684294. eCollection 2016.

本文引用的文献

1
Type 2 diabetes in older people; the importance of blood pressure control.老年人2型糖尿病;血压控制的重要性。
Curr Cardiovasc Risk Rep. 2013 Jun;7(3):233-237. doi: 10.1007/s12170-013-0301-5.
2
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.卡格列净在 2 型糖尿病合并慢性肾脏病患者中的疗效和安全性。
Diabetes Obes Metab. 2013 May;15(5):463-73. doi: 10.1111/dom.12090. Epub 2013 Mar 28.
3
Renal impairment has no clinically relevant effect on the long-term exposure of linagliptin in patients with type 2 diabetes.肾功能损害对 2 型糖尿病患者长期使用利拉利汀的暴露无临床相关影响。
Am J Ther. 2013 Nov-Dec;20(6):618-21. doi: 10.1097/MJT.0b013e31826232dc.
4
Obesity and the Cardiorenal Metabolic Syndrome: Therapeutic Modalities and Their Efficacy in Improving Cardiovascular and Renal Risk Factors.肥胖与心肾代谢综合征:治疗方式及其在改善心血管和肾脏危险因素方面的疗效
Cardiorenal Med. 2012 Dec;2(4):314-327. doi: 10.1159/000343803. Epub 2012 Nov 24.
5
Visit-to-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetes.血压变异性与 2 型糖尿病患者糖尿病肾病的发生和进展有关。
Diabetes Care. 2013 Jul;36(7):1908-12. doi: 10.2337/dc12-2087. Epub 2013 Jan 22.
6
A difference in systolic blood pressure between arms and between lower limbs is a novel risk marker for diabetic nephropathy in patients with type 2 diabetes.手臂和下肢之间的收缩压差异是 2 型糖尿病患者糖尿病肾病的一个新的风险标志物。
Hypertens Res. 2013 May;36(5):403-7. doi: 10.1038/hr.2012.207. Epub 2013 Jan 17.
7
Therapeutic Modalities in Diabetic Nephropathy: Future Approaches.糖尿病肾病的治疗方式:未来方法
Open J Nephrol. 2012 Jun 25;2(2):5-18. doi: 10.4236/ojneph.2012.22002.
8
DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy.二肽基肽酶-4 抑制剂联合血管紧张素受体阻断剂为糖尿病肾病提供了一种新的治疗方法。
Kidney Blood Press Res. 2012;36(1):119-30. doi: 10.1159/000341487. Epub 2012 Oct 15.
9
Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases.血压变异性与心血管和肾脏疾病进展的风险。
Curr Opin Nephrol Hypertens. 2013 Jan;22(1):59-64. doi: 10.1097/MNH.0b013e32835b489f.
10
Inflammation and the pathogenesis of diabetic nephropathy.炎症与糖尿病肾病发病机制。
Clin Sci (Lond). 2013 Feb;124(3):139-52. doi: 10.1042/CS20120198.

糖尿病肾病与心脏-肾脏综合征:旧病新视角。

Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives.

机构信息

Hospital Medicine, Department of Internal Medicine, University of Missouri, One Hospital Drive, Columbia, MO 65212, USA; Diabetes and Cardiovascular Research Center, University of Missouri, One Hospital Drive, Columbia, MO 65212, USA.

出版信息

Endocrinol Metab Clin North Am. 2013 Dec;42(4):789-808. doi: 10.1016/j.ecl.2013.06.002. Epub 2013 Aug 1.

DOI:10.1016/j.ecl.2013.06.002
PMID:24286950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4251585/
Abstract

In this article, the literature is reviewed regarding the role of blood pressure variability and nocturnal nondipping of blood pressure as well as the presence of diabetic kidney disease (DKD), in the absence of albuminuria, as risk predictors for progressive DKD. The importance of glycemic and blood pressure control in patients with diabetes and chronic kidney disease, and the use of oral hypoglycemic agents and antihypertensive agents in this patient cohort, are also discussed.

摘要

本文回顾了血压变异性和夜间血压非杓型以及在没有蛋白尿的情况下存在糖尿病肾脏疾病(DKD)作为进行性 DKD 的风险预测因子的文献。还讨论了血糖和血压控制在糖尿病和慢性肾脏病患者中的重要性,以及在这一患者群体中使用口服降糖药和抗高血压药的问题。